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Abstract
Background: Insulin resistance and diabetes are associated with increased oxidative stress and impairment of cellular defence
systems. Our purpose was to investigate the interaction between glucose metabolism, antioxidative capacity and heat shock
protein (HSP) defence in different skeletal muscle phenotypes among middle-aged obese subjects during a long-term exercise
and dietary intervention. As a sub-study of the Finnish Diabetes Prevention Study (DPS), 22 persons with impaired glucose
tolerance (IGT) taking part in the intervention volunteered to give samples from the vastus lateralis muscle. Subjects were divided
into two sub-groups (IGTslow and IGTfast) on the basis of their baseline myosin heavy chain profile. Glucose metabolism,
oxidative stress and HSP expressions were measured before and after the 2-year intervention.
Results: Exercise training, combined with dietary counselling, increased the expression of mitochondrial chaperones HSP60
and glucose-regulated protein 75 (GRP75) in the vastus lateralis muscle in the IGTslow group and that of HSP60 in the IGTfast
group. In cytoplasmic chaperones HSP72 or HSP90 no changes took place. In the IGTslow group, a significant positive
correlation between the increased muscle content of HSP60 and the oxygen radical absorbing capacity values and, in the IGTfast
group, between the improved VO2max value and the increased protein expression of GRP75 were found. Serum uric acid
concentrations decreased in both sub-groups and serum protein carbonyl concentrations decreased in the IGTfast group.
Conclusion: The 2-year intervention up-regulated mitochondrial HSP expressions in middle-aged subjects with impaired
glucose tolerance. These improvements, however, were not correlated directly with enhanced glucose tolerance.
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Diabetes and its complications are increasing as major
causes of mortality and morbidity in the developed coun-
tries [1]. Insulin resistance and diabetes are associated
with increased oxidative stresmpaired cellular defence sys-
tems [2-4]. We have recently shown in rats that streptozo-
tocin-induced diabetes (SID) increase oxidative stress and
resulted in impaired heat shock protein (HSP) responses
in liver and skeletal muscle tissue [2]. HSPs are a family of
proteins that promote cell survival after a wide variety of
environmental stresses. The most widely studied HSP
family is the 70-kDA family, which contains the constitu-
tive HSP73 and inducible HSP72 forms. HSP72 plays a
central role in protein synthesis, translocation, folding
and assembly/disassembly of multimetric protein com-
plexes as molecular chaperones [5]. In type 2 diabetic sub-
jects, insulin resistance correlates with decreased
expression of HSP72 in skeletal muscle [6]. HSP60 and
glucose-regulated protein 75 (GRP75) are located in the
mitochondria, where they are involved in the trafficking
and processing of nuclear encoded peptides [7,8]. HSP90
is expressed in the cytosol, nucleus and endoplasmic retic-
ulum [9] and has several physiological roles, including
mediating tyrosine kinase receptor maturation and pro-
tein kinase B (PKB/AKT) stability, an important activator
of glucose transports systems [9,10]. A number of studies
have shown the expression of HSPs to vary depending on
the muscle fibre type [11-13].
Oxidative stress, in which the increased production of
reactive oxygen species (ROS) overwhelms endogenous
antioxidant protection, may result in biomolecular dam-
age. However, at lower concentrations, ROS also serve as
secondary messengers, regulating cellular functions and
adaptations. ROS have important role in signal transduc-
tion pathways involved in cell growt h, proliferation and
differentiation, as the mitogen-activated protein kinase
(MAPK) pathways [14] Oxidative stress may have an
important role in the pathophysiology of insulin resist-
ance and diabetes and its complications through
increased oxidative damage, inflammation and apoptosis
[15-17]. Recent in vitro and in vivo studies have also shown
that the antioxidant supplementation suppresses ROS
production and improves glucose tolerance and insulin
sensitivity [18].
Strategies to decrease oxidative stress and to modulate
HSP expression may have important implications for
reducing insulin resistance and increasing the protection
against diabetes and its complications. Very little is
known about the effects of exercise and dietary interven-
tions on the antioxidant defence and protection of HSPs
in humans with impaired glucose metabolism [6,19],
although information is available in different animal
models [2]. Our purpose was to study whether a 2-year
exercise and dietary intervention improves the antioxida-
tive capacity and HSP defence of different skeletal muscle
fibre phenotypes in middle-aged obese subjects with
impaired glucose tolerance. Furthermore, we aimed to
investigate the association of tissue defences with
improved glucose metabolism.
Methods
This study is a sub-study of the Finnish Diabetes Preven-
tion Study (DPS), which has been described in detail else-
where [20,21]. This sub-study was carried out in Turku
with 22 subjects who volunteered to give muscle samples.
The intervention started with intensive dietary counsel-
ling [20,22]. After 6 months, a supervised, progressive and
individually tailored circuit-type resistance training pro-
gram started. Blood samples for metabolic indices were
taken at baseline and after 2 years and maximal exercise
test and muscle sampling (with no heavy exercising dur-
ing the preceding 2 days) were performed at 6 months and
after 2 years. In skeletal muscle glucose metabolism, the
greatest changes due to the dietary counselling were
assumed to have occurred by 6 months. While this gives a
good view of the changes in the regulation of the skeletal
muscle metabolism induced by exercise, it does not allow
us to distinguish the effects of either exercise or dietary
counselling separately.
Subjects
A total of 110 obese subjects with impaired glucose toler-
ance (IGT), were randomized to an intervention or a con-
trol group, based on two oral glucose tolerance tests. IGT
was defined as 2-hour plasma glucose concentration from
7.8 to 11.0 mmol/l in oral glucose tolerance test (OGTT)
with an intake of 75 g glucose in subjects whose fasting
plasma glucose concentration was less than 7.8 mmol/l
[23]. The test was repeated for subjects showing abnormal
values, and the mean of the two 2-hour plasma glucose
values was used as the inclusion criterion [20,22]. Twenty-
two persons from the intervention group volunteered to
give samples from their vastus lateralis muscle (n = 6 for
females, n = 16 for males). Depending on the proportion
of muscle myosin heavy chain II (MHC II) fibres, the sub-
jects were divided into IGTslow group (less than 55% of
MHC II fibres) or the IGTfast group [24]. The baseline
characteristics of the subjects are shown in Table 1. The
Ethical Committee of the Hospital District of South-West
Finland, Turku, Finland and the Ethical Committee of the
Rehabilitation Research Centre of the Social Insurance
Institution of Finland approved the protocol of this sub-
study. All subjects gave their written informed consent.
Intervention
The main goals of the intervention were as follows: 1)
weight reduction of 5% or more, 2) less than 30% of the
daily energy intake from fat, 3) less than 10% of the dailyPage 2 of 11
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per 1000 kcal or more, and 5) moderately intense physical
activity for 30 minutes per day or more. The implementa-
tion of the intervention program has been reported previ-
ously [20-22]. Briefly, the participants in the intervention
group were given detailed and individualized counselling
to achieve the set lifestyle goals. They had seven individual
counselling sessions with the nutritionist during the first
year and every three months thereafter. During the first 6
months, the intervention focused on dietary counselling,
in order to allow the subjects to concentrate on changing
their eating habits. The subjects were also individually
encouraged by the nutritionist to increase their physical
activity, and later on, to participate both in regular resist-
ance training at gym and in aerobic exercise.
After 6 months, supervised exercise training twice a week
was added to the intervention program [24]. The super-
vised training was progressive and individually designed,
consisting mostly of strength and power training, inter-
rupted by spinning exercises and aerobic gymnastic exer-
cises. Power-type strength training at a fitness centre was
performed as circuit training. Any physical activity lasting
30 min or longer was recorded by the participants. The
subjects were advised to exercise with moderate-to-inten-
sive effort for at least 30 min per session and three to four
times a week. Eighteen of 22 participants attended to
supervised training sessions at least once a week, but most
of them twice or three times a week (range: 77–249 ses-
sions) at a fitness centre. In addition, they trained by walk-
ing or other type of endurance exercises (range: 51–413
sessions). Only four participants did not attend regularly
to the supervised training sessions, but they participated
regularly in endurance type of sports or sports promoting
muscular fitness or walking sessions (range: 105–554 ses-
sions). Total amount of training varied from 105 to 584
sessions during the 2-year intervention period.
Muscle biopsy
A skeletal muscle biopsy was taken under resting condi-
tion (no heavy exercising during the preceding 2 days)
from the vastus lateralis muscle under local anaesthesia
(lidocaine 10 mg/ml), using the 'semi-open' conchotomy
technique [25]. Muscle samples were divided two separate
pieces (approximately 40–60 mg) and immediately fro-
zen in liquid nitrogen and stored at -70°C until analyzed.
Samples for biochemical analyses were melted in an ice
bath, weighed and homogenized in 1:50 (w/v) of 1 M Tris
buffer pH adjusted to 7.5 in a manually operated all-glass
homogenizer [26]. The enzyme activities[24] was meas-
ured immediately from the fresh homogenate and the rest
of the homogenate were aliquots to five to six separate
ependorf tubes and used for Western blot and ELISA anal-
yses. The other piece of the muscle samples were used for
the determination of myosin heavy chain profile.
Exercise test and maximal oxygen uptake (VO2max)
A 2-min incremental cycle ergometer test until volitional
exhaustion or fatigue of the lower limbs was employed to
measure the maximal oxygen uptake (VO2max). The warm-
up loading was 30–40 W in women and 40–60 W in men,
depending on the age, size and physical fitness of the sub-
jects. Thereafter, work rate was increased every 2nd min
with equal increments (10–25 W) throughout the test.
The increments were individually determined on the basis
of the subject's physical fitness so that the maximum work
rate would be reached in about 12–15 min [27]. Respira-
tory gas exchange was measured continuously by using a
breath-by-breath method. VO2max was recorded as the
highest averaged value over 30 s at the work rate maxi-
mum [27].
Assessment of dietary intake
Nutrient intakes were assessed using a dietary analysis
program developed by the National Public Health Insti-
tute [28]. At baseline and before the 24-month visit, the
subjects were asked to complete a three-day food record
[29,30].
Determination of myosin heavy chain profile
The MHC isoform composition (MHC I, MHC IIa, MHC
IIx) in muscle homogenate was determined by SDS-PAGE
gel electrophoresis [31] by using a Bio-Rad Protean II Xi
vertical slab gel system. The acrylamide and bis concentra-
tion were 4% in the stacking gel and 7.2% (w/vol) in the
separating gel, and the gel matrix included 30% glycerol.
Electrophoresis lasted 24 h at 120 V and +10°C. The gels
Table 1: Baseline characteristics of the subjects with impaired 
glucose tolerance (IGT) divided into the slow and fast fibre type 
sub-groups.
Characteristics IGTslow IGTfast
n = (Female/Male) 10 (4/6) 12 (2/10)
Age, yr 58.5 ± 2.0 54.1 ± 2.0
BMI (kg/m2) 29.9 ± 0.7 29.9 ± 0.7
Weight, kg 86.9 ± 2.8 92.0 ± 2.2
Myosin heavy chain profile
MHC I, % 46.4 ± 2.9 30.6 ± 1.0***
MHC IIa, % 36.9 ± 3.5 47.2 ± 2.0**
MHC IIx, % 16.7 ± 3.3 22.2 ± 2.1
Blood chemistry
Fp-glucose, mmol/l 6.0 ± 0.2 6.0 ± 0.1
2h-glucose, mmol/l 7.8 ± 0.3 7.5 ± 0.5
Fs-insulin, μU/ml 12.9 ± 1.0a 19.5 ± 2.7* b
2 h-insulin, μU/ml 72 ± 13a 117 ± 35b
HbA1c, % 5.7 ± 0.1 5.7 ± 0.1
HOMA-IR 3.5 ± 0.3a 5.2 ± 0.7b
Data are given as means ± SE; * P < 0.05; ** P < 0.01, *** P < 0.001 a n 
= 9, b n = 11, Kruskall-Wallis test for difference between the groups.Page 3 of 11
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CA, USA) and analyzed using computer-based image
analysis system and software (Image Master 1D Elite,
Amersham Pharmacia Biotech, Uppsala, Sweden).
Western blot assays
Western blot assays were performed as described previ-
ously [2,32]. One-dimensional sodium dodecyl sulfate
polyacrylamide (10%) gel electrophoresis was done to
separate proteins according to their molecular weight. The
blots were incubated overnight at +4°C with the follow-
ing antibodies: anti-HSP60 (SPA-806), anti-HSP72 (SPA-
810), anti-GRP75 (SPA-825), anti-HSP-90 (SPA-835)
(Stressgen, Victoria, BC, Canada) and anti-4-HNE (210-
767-R100) (Alexis Biochemical, San Diego, CA, USA).
Horseradish peroxidase-conjugated immunoglobulins
were used as secondary antibodies. Antibody binding was
viewed by using an enhanced chemiluminescence
method (NEN Life Science Products, Boston, MA, USA)
and quantified by using the image analysis software (NIH-
Image, MD, USA). The results were normalized according
to beta-actin (LabVision/NeoMarkers, Fremont, CA, USA)
values. The protein concentration of homogenates was
measured by using BCA method (Pierce, Rockford, IL,
USA).
Elisa assay for protein carbonyls of skeletal muscle and 
serum samples
Protein carbonyls were measured with a slightly modified
method according to Buss et al. [33] and Oksala et al. [34].
Briefly, protein derivation was carried out in 1.5 ml reac-
tion tubes. Forty-five μl of dinitrophenylhydrazine (DNP)
solution [35] was added to a 15 μl sample. A final protein
concentration was 1 mg/ml. Absorbances were read with
a 490 nm filter using a micro plate reader. The absorbance
of the blank sample in PBS without protein was sub-
tracted from all other absorbances. A seven-point stand-
ard curve of oxidized BSA (Sigma, Germany) was included
with each plate [34].
Blood chemistry
Plasma glucose was analyzed enzymatically with hexoki-
nase (Olympus Diagnostica, Hamburg, Germany) and
serum insulin by radioimmunoassay (Pharmacia, Upp-
sala, Sweden). Hemoglobin A1c (HbA1c) concentration
was assayed by using the latex immunoagglutination inhi-
bition method (Bayer Corporation, Elkhart, IN, USA:
DCA, 2000 Reagent Kit). Insulin resistance was deter-
mined by the homeostasis model assessment for insulin
resistance (HOMA-IR) as described by Matthews et al.
[36]. Serum uric acid was determined photometrically by
the hydroxylamine method [37]. Oxygen radical absorb-
ing capacity (ORAC) was assayed by using a multi-well
plate reader according to the methods described else-
where [38,39]. Briefly, the antioxidant capacity of the
samples was measured by the inhibition of the decrease of
the fluorescence. For this purpose, fluorescein was used as
a target of free radical attack, with 2,2'-azobis (2-amidino-
propane) dihydrochloride as a peroxyl radical generator.
Statistical analysis
Data are reported as means ± standard error (SE). Stu-
dent's paired t test was used to assess differences within
groups (baseline and 2-year follow-up) and Kruskall-Wal-
lis test for difference between the groups. Pearson's corre-
lation coefficients were used to express the associations
between the variables.
Results
Glucose homeostasis, aerobic capacity, oxidative stress 
and its defence mechanisms in subjects with IGT
Baseline and 2-year follow-up values of the IGT subjects
(n = 22) are shown in Table 2. Body weight decreased by
-4.4 kg (4.9%) (P < 0.001). In addition, the fasting glu-
cose, 2-h glucose, HbA1c, serum protein carbonyl and uric
acid concentrations decreased significantly in the IGT sub-
jects (Table 2). Maximal oxygen uptake variables (VO2max
and VO2max/weight) and the protein content of GRP75
Table 2: Indices of glucose m etabolism, weight, m axim al oxygen uptake and oxidative stress in the subjects with im paired glucose 
tolerance (IGT), n = 22.
Baseline 2-year follow-up Change P value
Fp-glucose, m m ol/l 6.0 ± 0.1 5.8 ± 0.1 -0.3 ± 0.1 0.013
2h-glucose, m m ol/l 7.7 ± 0.3 6.4 ± 0.4 -1.2 ± 0.5 0.013
HbA1c, % 5.7 ± 0.1 5.4 ± 0.1 -0.4 ± 0.1 <0.001a
W eight, kg 89.7 ± 1.8 85.3 ± 2.0 -4.4 ± 1.1 <0.001
BM I (kg/m2) 29.9 ± 0.5 28.4 ± 0.5 -1.5 ± 0.4 <0.001
VO2max, l/min 2.28 ± 0.14 2.43 ± 0.13 0.2 ± 0.0 <0.001
VO2max/weight, ml/kg/min 26.1 ± 1.6 28.5 ± 1.5 2.4 ± 0.6 <0.001
GRP75 (muscle), arb. u. 0.95 ± 0.11 1.28 ± 0.16 0.33 ± 0.12 0.014
HSP60 (muscle), arb. u. 0.35 ± 0.05 0.56 ± 0.11 0.21 ± 0.08 0.022
P. carbonyls (serum), arb. u. 0.12 ± 0.00 0.11 ± 0.00 -0.00 ± 0.00 0.010b
Uric acid, μmol/l 375 ± 12 337 ± 14 -37 ± 9 0.001
Data are given as m eans ± SE; arb. u. = arbitrary units, a n = 21, b n = 20Page 4 of 11
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pre-intervention values (Table 2).
Comparison of IGT sub-groups
At baseline, HbA1c was similar in the IGTslow and IGTfast
group, while HOMA-IR was 49% (1.7 units) higher (P =
0.087) in the IGTfast group (Table 3). Most of the meas-
ured markers of oxidative stress and antioxidative capacity
of serum and skeletal muscle were similar between the
groups. The serum protein carbonyl concentration was,
however 17% higher in the IGTslow than in the IGTfast
group (P = 0.002, Table 3). The total energy intake and
vitamin C were similar at baseline, but the vitamin E
intake was 34% (4.2 mg/day) lower in the IGTslow than
in the IGTfast group (P = 0.003).
During the 2-year intervention, there were no significant
changes in the energy intake or vitamin C in the IGTslow
and IGTfast groups. Vitamin E intake was lower in the
IGTslow than in the IGTfast group during the whole study
period (Figure 1). During the follow-up period, body
weight reduced by 5.1 (SD 6.2; range: 0.3 to -9.9) kg in the
IGTfast group and by 3.6 (SD 3.2; range: 3.0 to -14.5) kg
in the IGTslow group [24]; but the difference between the
groups was not statistically significant.
Maximal oxygen uptake variables increased and HbA1c
concentrations decreased in both groups but HOMA-IR
values decreased only in the IGTfast group (Table 3).
Serum concentrations of uric acid decreased significantly
in both groups (Table 3), but serum protein carbonyl con-
centrations decreased only in the IGTfast group (P =
0.0213). After 2 years, the serum protein carbonyl concen-
trations were still higher in the IGTslow than in the IGT-
fast group (P = 0.015) (Table 3). The intervention period
did not significantly affect the ORAC values in either
group (Table 3). There were no changes in protein oxida-
tion or lipid peroxidation in the skeletal muscle in either
group (Table 3).
Chaperone responses
During the intervention, the expression of mitochondrial
HSP60 increased (79% in the IGTslow and 38% IGTfast
group) significantly in both groups (IGTslow: P = 0.034
and IGTfast: P = 0.029) and GRP75 increased (38%) sig-
nificantly in the IGTslow group (P = 0.022), while only a
tendency was recorded in the IGTfast group (P = 0.072;
Figure 2). On the other hand, no changes were observed
in the cytoplasmic chaperones HSP72 or HSP 90 in either
of the groups (Figure 3).
There were positive correlations between the increase of
muscle HSP60 and the increase of the serum ORAC values
(r = 0.92; P = 0.001) in the IGTslow group (Figure 4). The
improvement of maximal oxygen uptake (VO2max/weight)
correlated negatively with decreased weight (r = -0.617; P
= 0.033) and 2-h glucose (r = -0.613; P = 0.034) and the
improved VO2max value correlated positively with the
increase of protein expression of GRP75 (r = 0.750; P =
0.005) in the IGTfast group and negatively in the IGTslow
group (r = -0.842; P = 0.004) (Figure 5).
Discussion
This is the first study to investigate the HSP responses in
human skeletal muscle tissue during a long-term exercise-
diet intervention. After the intervention period, oxidative
stress was reduced as shown by decreased serum levels of
uric acid and protein carbonyls, and cytoprotection was
improved in the skeletal muscle tissue, observed as the
increased expression of mitochondrial HSP60 and GRP75
Table 3: Indices of glucose m etabolism and oxidative stress from serum and skeletal m uscle sam ples, as well as m axim al oxygen 
uptake in the subjects with im paired glucose tolerance (IGT) divided into two muscle phenotype groups.
IGTslow subjects Baseline 2-year follow-up IGTfast subjects Baseline 2-year follow-up
n = (Female/Male) 10 (4/6) 12 (2/10)
Serum
HbA1c, % 5.74 ± 0.13 5.38 ± 0.08* 5.67 ± 0.11 5.33 ± 0.14**
HOM A-IR 3.52 ± 0.30 3.22 ± 0.51 5.23 ± 0.75 3.77 ± 0.71*
ORAC, μmol 56.0 ± 4.5 58.2 ± 3.1 54.0 ± 3.4 55.4 ± 3.2
P. carbonyl, arb.u. 0.129 ± 0.005 0.126 ± 0.00 0.110 ± 0.003## 0.106 ± 0.003* ##
Uric acid, μmol/l 370 ± 17 331 ± 18** 379 ± 17 342 ± 21*
Skeletal muscle
P. carbonyl, arb.u. 0.074 ± 0.011 0.071 ± 0.008 0.072 ± 0.007 0.070 ± 0.005
4-HNE, arb.u. 0.29 ± 0.07 0.24 ± 0.04 0.25 ± 0.04 0.26 ± 0.04
Maximal oxygen uptake
VO2max, l/min 1.96 ± 0.22a 2.10 ± 0.20* a 2.52 ± 0.15 2.69± 0.15**
VO2max, /weight ml/kg/min 23.3 ± 2.7a 25.3 ± 2.4* a 28.2 ± 1.7 30.9 ± 1.6**
Data are given as means ± SE; *P < 0.05, ** P < 0.01 within group; #P < 0.05, ##P < 0.01 between groups;a n = 9.Page 5 of 11
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plasmic chaperones HSP72 and HSP90.
In this study, we aimed to investigate if the muscle fibre
composition is associated with the above improvements,
and hence the IGT subjects were into two sub-groups (IGTfast and IGTslow). In general, men and women have,
on an average, 45% and 55% of MHC I fibers (slow oxi-
dative fibers) [40,41]. In our study, the muscle fibre com-
position of the two sub-groups differed significantly [24],
The fibre type composition remained unchanged in the
two subject groups, although the exercise training slightly
Relationship between the changes of the HSP60 and ORAC values during a 2-year interve tion in subjects with impaired gluco e tolerance (IGT), divided i to slow (n = 8) and fast (n= 12) fibre typ  sub-groupsFigur 4
Relationship between the changes of the HSP60 and 
ORAC values during a 2-year intervention in subjects 
with impaired glucose tolerance (IGT), divided into 
slow (n = 8) and fast (n = 12) fibre type sub-groups.
(A) Effects of the 2-year intervention on the protein expres-sion of GRP75 and HSP60 in th  vastus lateralis muscl  of sub-jects with impaired glucose tol rance (IGT), divid d intol w (n = 10) nd fast (n= 12) fibre ype sub-g psFigur 2
(A) Effects of the 2-year intervention on the protein 
expression of GRP75 and HSP60 in the vastus lateralis 
muscle of subjects with impaired glucose tolerance 
(IGT), divided into slow (n = 10) and fast (n = 12) 
fibre type sub-groups. Data are given as means ± SE. *P < 
0.05 within groups. (B) Representative Western blots, using 
anti-GRP75 and beta-actin antibodies, of whole tissue 
homogenates from skeletal muscle biopsies of four IGT sub-
jects at baseline (0) and after 2-year follow-up (2).
Dietary vitamin C and E intakes during a 2-year intervention in subjects with impaired gluco e tolerance (IGT), divided to slow (n = 10)  fast (n = 12) fibre typ  sub-groupsFig r 1
Dietary vitamin C and E intakes during a 2-year 
intervention in subjects with impaired glucose toler-
ance (IGT), divided into slow (n = 10) and fast (n = 
12) fibre type sub-groups.
(A) Effects of the 2-year intervention on the protein expres-sion of HSP72 and HSP90 in th  vastus lateralis muscle of sub-jects with impaired glucose tol rance (IGT), divid d into l w (n = 10) nd fast (n = 12) fibre type sub-groupsFigur 3
(A) Effects of the 2-year intervention on the protein 
expression of HSP72 and HSP90 in the vastus lateralis 
muscle of subjects with impaired glucose tolerance 
(IGT), divided into slow (n = 10) and fast (n = 12) 
fibre type sub-groups. Data are given as means ± SE. *P < 
0.05 within groups. (B) Representative Western blots, using 
anti-HSP72 and beta-actin antibodies, of whole tissue 
homogenates from skeletal muscle biopsies of four IGT sub-
jects at baseline (0) and after 2-year follow-up (2).Page 6 of 11
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(n.s) the proportion of MHC IIx isoforms in the vastus lat-
eralis muscle in IGTslow group [24]. Otherwise, there were
no differences between the sub-groups in physical activity
or in dietary intake before or during the intervention,
except for vitamin E intake at baseline.
Chaperones and exercise
Physical inactivity is one of the major non-genetic deter-
minants of type 2 diabetes. In the present study, the
improvement of maximal oxygen uptake in both sub-
groups shows that the exercise training protocol was effec-
tive. Presumably, the increased expression of mitochon-
drial HSP60 and GRP75 in vastus lateralis muscle in the
IGTslow group and that of HSP60 in the IGTfast group
were responses to our intervention program. Induced
HSP60 and HSP72 expressions in skeletal muscle have
also been reported in a short-term exercise intervention in
healthy humans [42,43]. Consistently, 8 weeks of endur-
ance training increased GRP75 expression in red gastrocne-
mius muscle of streptozotocin-induced diabetic (SID) rats
as well as non-diabetic control rats [2]. In addition, we
have recently shown that after four weeks of immobiliza-
tion, acute intensive non-damaging exercise up-regulated
especially HSP60 expression in the plantaris and gastrocne-
mius muscles in rats [32]. Furthermore, Mattson et al. [44]
have reported that both HSP60 and GRP75 are up-regu-
lated in rat skeletal muscle after 8 weeks of endurance
training. In those studies, up-regulation of HSP60 and
GRP75 was associated with increased skeletal muscle cit-
rate synthase activity (CS) [2,44]. Menshikova et al. [45]
have recently shown that a 4 month walking combined
with weight-loss increased CS activity 29 ± 9% in previ-
ously sedentary obese men and women and induced
mitochondrial biogenesis in skeletal muscle. Our exercise
program also increased CS activity in vastus lateralis mus-
cle in both groups (34% in the IGTslow and 20% IGTfast
group) [24]. However, we did not find any correlation
between increased CS activity and HSP60 or GRP75
expression. On the other hand, the improvement in
VO2max correlated positively with increased protein
expression of GRP75 in the IGTfast group but not with the
weight loss.
Diabetes has been reported to cause mitochondrial dys-
function and attenuated synthesis of a variety of proteins,
including HSP60 in mitochondria [46,47]. The skeletal
muscle insulin resistance and mitochondrial dysfunction
are associated with ageing, type 2 diabetes and in off-
spring of type 2 diabetes [48]. The reduced oxidative activ-
ity could also be a result of a sedentary lifestyle, and no
data on correlations between changes in oxidative capac-
ity and insulin sensitivity following exercise in type 2 dia-
betes have been published [49]. The capacity of HSP60 to
stabilize mitochondrial proteins, promote mitochondrial
protein biosynthesis and to prevent mitochondrial apop-
tosis seems to be crucial for its protective function [50]. In
the present study, the adaptive changes in the expression
of GRP75 and HSP60 could support mitochondrial pro-
tein import, protein folding and enhance tissue protection
in insulin-resistant muscle tissue. These adaptive changes
of mitochondrial HSPs and increased oxidative capacity
are mainly due to increased contractile activity of skeletal
muscle. However, Civitarese et al. [51] have recently
shown in young obese subjects that six months caloric
restriction alone, or with exercise reduces DNA damage
and increases muscle mitochondrial biogenesis (up regu-
lation of genes involving mitochondrial function) with-
out any increase of oxidative enzymes including CS.
Skeletal muscle from obese subjects contains a smaller
number of mitochondria because of the lower ratio of
type 1 to type 2 muscle fibers and have reduced oxidative
capacity [45,52]. Several genes acting in antioxidative
processes against oxidative stress are defective in diabetic
subjects and correlate with the oxidative capacity [19,52].
Exercise activates PGC-1α, which mainly mediates tran-
scriptional regulation of nuclear genes encoding mito-
chondrial proteins (NGEMP). These nuclear-derived gene
products have to import into mitochondria via the pro-
tein-import machinery. Imported NGEMPs interact with
GRP75, and GRP75 drives translocation of these precur-
sors across the mitochondrial matrix. In an ATP-depend-
ent process precursors are released and bound to the
HSP60. Therefore, both GRP75 and HSP60 are essential
for mitochondrial function and biogenesis [17]. Also, it
has recently been shown that the basal expression of
Relationship between the changes of the GRP75 and VO2max values during a 2-year interve tion in subjects with impaired gluco e tolerance (IGT), divided i to slow (n = 9) and f st (n= 12) fibre typ  sub-groupsFigur 5
Relationship between the changes of the GRP75 and 
VO2max values during a 2-year intervention in sub-
jects with impaired glucose tolerance (IGT), divided 
into slow (n = 9) and fast (n = 12) fibre type sub-
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betics, compared with healthy control subjects, which
may lead to an imbalance of antioxidant defence mecha-
nism [19].
In the present study, interestingly the expression of the
cytoplasmic HSP72 and HSP90 in skeletal muscle was not
affected by the exercise-diet intervention in either of the
study groups. Most studies showing that exercise induced
HSP72 [19], have used low force exercises with continu-
ous activity. However, Gjovaag et al. [53] have shown that
high force exercise with intermittent activity like weight
training decrease HSP72 expression in very well trained
males. In this study, we used similar type of supervised
strength and power-type exercise than Gjovaag et al., and
it may be one reason why our exercise program did not
increase the expression of the HSP72. On the other hand
since HSP induction is also dependent on the training lev-
els of the subjects prior to the exercise intervention
[54,55], we may not directly compare the responses of the
sedentary subjects with very well trained ones.
Furthermore, we aimed to investigate the association of
tissue defences with improved glucose metabolism. We
found a decrease of the 2-h glucose and HbA1c concentra-
tions in the IGTslow and IGTfast groups and a decrease of
the fasting glucose and HOMA-IR values in the IGTfast
group [24]. These results also agree with those presented
in a meta-analysis by Snowling and Hopkins [56] show-
ing that aerobic, resistance, and combined exercise have
small to moderate beneficial effects on glucose metabo-
lism in type 2 diabetic subjects. However, our findings did
not correlate with the markers of improved cytoprotection
of the skeletal muscle in either group. Fasting values of
glucose and insulin (HOMA-IR) are depending on the
hepatic glucose control, but not peripheral glucose metab-
olism. Petersen et al. [57] have show that improvements
in basal and insulin-stimulated hepatic glucose metabo-
lism were associated reduction in intrahepatic lipid (IHL)
(P = 0.0009) without significant changes in insulin-stim-
ulated peripheral glucose uptake after a moderate weight
loss (8% of their body weight). The improvement of the
VO2max/weight correlated negatively with the 2-h glucose
values at the 2-year follow-up in the IGTfast group.
Antioxidant capacity
In addition to the HSP responses, we studied the antioxi-
dant capacity as measured by ORAC in the serum. ORAC
concentrations were slightly increased in both study
groups during the intervention but the increase was not
statistically significant. In agreement with our results, a
combination of antioxidant mixture supplementation
and 24 days of cold-weather field training did not signifi-
cantly affect ORAC or other oxidative stress markers [4].
On the other hand, changes in the serum levels may not
always reflect the trainings adaptations gained in skeletal
muscle, especially if the samples were taken at rest. We,
however, found a significant positive correlation between
the increased content of HSP60 and the ORAC values in
the IGTslow group. No study has so far been published
investigating the association between the ORAC and HSP
levels. In studies applying other methods for antioxidant
capacity have been used, endurance training contributed
to the improved cardiac protection by enhancing the anti-
oxidant capacity and HSP induction [54,55].
No association was found between the improvements in
the glucose metabolism and the antioxidant capacity or
HSP defence during the intervention, although it has been
recently shown that, in type 2 diabetic subjects, insulin
resistance correlates with decreased expression of HSP72
in skeletal muscle at mRNA level [6].
Oxidative stress
Increased production of ROS is typical in type 2 diabetic
subjects [18,58]. Hyperglycemia decreases glutathione
synthesis and impairs the antioxidant defence [17,59].
One of the most toxic aldehydes formed during lipid per-
oxidation is 4-hydroxynonenal (HNE), which can dena-
ture proteins and form protein adducts. It has been
demonstrated that the induction of HSP72 is closely asso-
ciated with and regulated by 4-HNE protein adducts [60].
In the present study, however, we neither observed any
differences in the HSP72 expression nor 4-HNE protein
adduct levels in the skeletal muscles of the subjects with
impaired glucose tolerance. The only previously pub-
lished study has shown that both long-term exercise train-
ing and one week of intensive resistance training resulted
in increased 4-HNE, malondialdehyde (MDA) and thio-
barbituric acid-reactive substance (TBARS) levels in
female weightlifters [61]. The intensity of exercise in the
present study was not as high as in the Liu's study [61].
Protein carbonyls have been widely used marker of oxida-
tive modification of proteins. Elevated protein carbonyl
levels have been detected both in type 1 and type 2 and
also in experimental diabetes [2,15,62]. We observed a
small, but statistically significant decrease of plasma pro-
tein carbonyls after the intervention in the IGTfast group.
In agreement with our results, a recent study showed that
14 weeks of training decreased protein carbonyl content
and induced HSP60 expression without affecting HSP72
expression in the heart of doxorubicin treated mice [63].
Furthermore, moderate training decreased the protein car-
bonyl content in rat liver without affecting lipid peroxida-
tion [64].
Conclusion
To conclude, exercise training combined with dietary
counselling improved glucose metabolism and maximal
oxygen uptake in subjects with impaired glucose toler-Page 8 of 11
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vention increased the mitochondrial chaperones in the
skeletal muscle, while no changes took place in the cyto-
plasmic chaperones. The mitochondrial responses in the
IGTslow sub-group were slightly greater than in the IGT-
fast subgroup. The enhancement of mitochondrial HSP
defences may reduce glucose toxicity, since muscle mito-
chondria are important sources of oxygen derived radicals
and since insulin resistance and diabetes are associated
with increased oxidative stress.
Abbreviations
DPS: the Finnish Diabetes Prevention Study; GRP75: glu-
cose-regulated protein 75; HbA1c: Hemoglobin A1c; HNE:
4-hydroxynonenal; HOMA-IR: homeostasis model assess-
ment for insulin resistance; HSP: heat shock protein; IGT:
impaired glucose tolerance; IHL: intrahepatic lipid;
MAPK: mitogen-activated protein kinase; MHC: myosin
heavy chain; NGEMP: nuclear genes encoding mitochon-
drial proteins; ORAC: oxygen radical absorbing capacity;
PKB/AKT: protein kinase B; ROS: reactive oxygen species;
SID: streptozotocin-induced diabetes TBARS: thiobarbitu-
ric acid-reactive substance; VO2max: maximal oxygen
uptake.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
HH, JM and SA were responsible overall design of study.
MV, SA, MA and MG were responsible of the analysis of
the results and MV and SA for statistical analysis. MG per-
formed most of the biochemical analyses and MA and MV
provided technical guidance and advice for biochemical
methods. RP was performed MHC analysis. JPH was
responsible of taking off muscle biopsies. JL and MR were
responsible of dietary intervention and analysis. KH, OH,
and PN critically reviewed the manuscript, with important
impact of intellectual content. MV wrote the draft of the
manuscript. MA and SA provided the critical revision of
the manuscript. All the authors have read and approved
the final manuscript.
Acknowledgements
The authors wish to express their gratitude to Mrs. Minna Glad for excel-
lent technical assistance, to Mrs. Arja Kylliäinen for her assistance in statis-
tical analyses and to Mr. Antti Huuskonen for his editorial assistance. The 
study was supported by grants from the Research Council for Physical Edu-
cation and Sports, the Finnish Ministry of Education, the Juho Vainio Foun-
dation, Turku University of Applied Sciences R&D program and the COST 
Actions B35 and BM0602. Mika Venojärvi was supported by TULES Grad-
uate School.
References
1. Petersen KF, Shulman GI: New insights into the pathogenesis of
insulin resistance in humans using magnetic resonance spec-
troscopy.  Obesity (Silver Spring) 2006, 14 Suppl 1:34S-40S.
2. Atalay M, Oksala NK, Laaksonen DE, Khanna S, Nakao C, Lappalainen
J, Roy S, Hänninen O, Sen CK: Exercise training modulates heat
shock protein response in diabetic rats.  J Appl Physiol 2004,
97(2):605-611.
3. Muchova J, Liptakova A, Orszaghova Z, Garaiova I, Tison P, Carsky J,
Durackova Z: Antioxidant systems in polymorphonuclear leu-
cocytes of Type 2 diabetes mellitus.  Diabet Med 1999,
16(1):74-78.
4. Parthiban A, Vijayalingam S, Shanmugasundaram KR, Mohan R: Oxi-
dative stress and the development of diabetic complica-
tions– antioxidants and lipid peroxidation in erythrocytes
and cell membrane.  Cell Biol Int 1995, 19(12):987-993.
5. Bukau B, Horwich AL: The Hsp70 and Hsp60 chaperone
machines.  Cell 1998, 92(3):351-366.
6. Kurucz I, Morva A, Vaag A, Eriksson KF, Huang X, Groop L, Koranyi
L: Decreased expression of heat shock protein 72 in skeletal
muscle of patients with type 2 diabetes correlates with insu-
lin resistance.  Diabetes 2002, 51(4):1102-1109.
7. Kang PJ, Ostermann J, Shilling J, Neupert W, Craig EA, Pfanner N:
Requirement for hsp70 in the mitochondrial matrix for
translocation and folding of precursor proteins.  Nature 1990,
348(6297):137-143.
8. Martin J, Horwich AL, Hartl FU: Prevention of protein denatura-
tion under heat stress by the chaperonin Hsp60.  Science 1992,
258(5084):995-998.
9. Basso AD, Solit DB, Chiosis G, Giri B, Tsichlis P, Rosen N: Akt
forms an intracellular complex with heat shock protein 90
(Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90
function.  J Biol Chem 2002, 277(42):39858-39866.
10. Csermely P, Schnaider T, Soti C, Prohaszka Z, Nardai G: The 90-
kDa molecular chaperone family: structure, function, and
clinical applications. A comprehensive review.  Pharmacol Ther
1998, 79(2):129-168.
11. Liu Y, Steinacker JM: Changes in skeletal muscle heat shock
proteins: pathological significance.  Front Biosci 2001, 6:D12-25.
12. Locke M, Noble EG, Atkinson BG: Inducible isoform of HSP70 is
constitutively expressed in a muscle fiber type specific pat-
tern.  Am J Physiol 1991, 261(5 Pt 1):C774-9.
13. Ornatsky OI, Connor MK, Hood DA: Expression of stress pro-
teins and mitochondrial chaperonins in chronically stimu-
lated skeletal muscle.  Biochem J 1995, 311 (1):119-123.
14. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J: Free
radicals and antioxidants in normal physiological functions
and human disease.  Int J Biochem Cell Biol 2007, 39(1):44-84.
15. Dominguez C, Ruiz E, Gussinye M, Carrascosa A: Oxidative stress
at onset and in early stages of type 1 diabetes in children and
adolescents.  Diabetes Care 1998, 21(10):1736-1742.
16. Hotta M, Tashiro F, Ikegami H, Niwa H, Ogihara T, Yodoi J, Miyazaki
J: Pancreatic beta cell-specific expression of thioredoxin, an
antioxidative and antiapoptotic protein, prevents autoim-
mune and streptozotocin-induced diabetes.  J Exp Med 1998,
188(8):1445-1451.
17. Atalay M, Laaksonen DE: Diabetes, oxidative stress and physical
exercise.  J Sport Sci Med 2002, 1(1):1-14.
18. Houstis N, Rosen ED, Lander ES: Reactive oxygen species have a
causal role in multiple forms of insulin resistance.  Nature
2006, 440(7086):944-948.
19. Bruce CR, Carey AL, Hawley JA, Febbraio MA: Intramuscular heat
shock protein 72 and heme oxygenase-1 mRNA are reduced
in patients with type 2 diabetes: evidence that insulin resist-
ance is associated with a disturbed antioxidant defense
mechanism.  Diabetes 2003, 52(9):2338-2345.
20. Eriksson J, Lindström J, Valle T, Aunola S, Hämäläinen H, Ilanne-
Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Lauhkonen M, Lehto
P, Lehtonen A, Louheranta A, Mannelin M, Martikkala V, Rastas M,
Sundvall J, Turpeinen A, Viljanen T, Uusitupa M, Tuomilehto J: Pre-
vention of Type II diabetes in subjects with impaired glucose
tolerance: the Diabetes Prevention Study (DPS) in Finland.
Study design and 1-year interim report on the feasibility of
the lifestyle intervention programme.  Diabetologia 1999,
42(7):793-801.Page 9 of 11
(page number not for citation purposes)
BMC Endocrine Disorders 2008, 8:3 http://www.biomedcentral.com/1472-6823/8/321. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H,
Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A,
Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes
mellitus by changes in lifestyle among subjects with impaired
glucose tolerance.  N Engl J Med 2001, 344(18):1343-1350.
22. Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriks-
son J, Uusitupa M, Tuomilehto J: The Finnish Diabetes Preven-
tion Study (DPS): Lifestyle intervention and 3-year results
on diet and physical activity.  Diabetes Care 2003,
26(12):3230-3236.
23. World Health Organization: World Health Organization: Diabe-
tes mellitus.  In Report of a WHO Study Group. Techical Report Series
No 727 Geneva ; 1985. 
24. Venojärvi M, Puhke R, Hämäläinen H, Marniemi J, Rastas M, Rusko H,
Nuutila P, Hänninen O, Aunola S: Role of skeletal muscle-fibre
type in regulation of glucose metabolism in middle-aged sub-
jects with impaired glucose tolerance during a long-term
exercise and dietary intervention.  Diabetes Obes Metab 2005,
7(6):745-754.
25. Henriksson KG: "Semi-open" muscle biopsy technique. A sim-
ple outpatient procedure.  Acta Neurol Scand 1979,
59(6):317-323.
26. Aunola S, Marniemi J, Alanen E, Mäntylä M, Saraste M, Rusko H: Mus-
cle metabolic profile and oxygen transport capacity as deter-
minants of aerobic and anaerobic thresholds.  Eur J Appl Physiol
Occup Physiol 1988, 57(6):726-734.
27. Surakka J, Alanen E, Aunola S, Karppi SL, Pekkarinen H: Effects of
external light loading in power-type strength training on
muscle power of the lower extremities in middle-aged sub-
jects.  Int J Sports Med 2006, 27(6):448-455.
28. Ovaskainen ML, Valsta LM, Lauronen J: The compilation of food
analysis values as a database for dietary studies – The Finnish
experience.  Food Chemistry 1996, 57(1):133-136.
29. Haapa E, Toponen T, Pietinen P, Räsänen L: Annoskuvakirja.  Hel-
sinki , Painokaari Oy.; 1985. 
30. Pietinen P, Hartman AM, Haapa E, Räsanen L, Haapakoski J, Palmgren
J, Albanes D, Virtamo J, Huttunen JK: Reproducibility and validity
of dietary assessment instruments. I. A self-administered
food use questionnaire with a portion size picture booklet.
Am J Epidemiol 1988, 128(3):655-666.
31. Hämäläinen N, Pette D: Slow-to-fast transitions in myosin
expression of rat soleus muscle by phasic high-frequency
stimulation.  FEBS Lett 1996, 399(3):220-222.
32. Venojärvi M, Kvist M, Jozsa L, Kalimo H, Hänninen O, Atalay M: Skel-
etal muscle HSP expression in response to immobilization
and remobilization.  Int J Sports Med 2007, 28(4):281-286.
33. Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC: Protein
carbonyl measurement by a sensitive ELISA method.  Free
Radic Biol Med 1997, 23(3):361-366.
34. Oksala NK, Laaksonen DE, Lappalainen J, Khanna S, Nakao C, Hänn-
inen O, Sen CK, Atalay M: Heat shock protein 60 response to
exercise in diabetes: effects of alpha-lipoic acid supplementa-
tion.  J Diabetes Complications 2006, 20(4):257-261.
35. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn
BW, Shaltiel S, Stadtman ER: Determination of carbonyl content
in oxidatively modified proteins.  Methods Enzymol 1990,
186:464-478.
36. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF,
Turner RC: Homeostasis model assessment: insulin resistance
and beta-cell function from fasting plasma glucose and insu-
lin concentrations in man.  Diabetologia 1985, 28(7):412-419.
37. Musser AW, Ortigoza C: Automated determination of uric acid
by the hydroxylamine method.  Tech Bull Regist Med Technol 1966,
36(2):21-25.
38. Kinnunen S, Hyyppä S, Lehmuskero A, Oksala N, Mäenpää P, Hänn-
inen O, Atalay M: Oxygen radical absorbance capacity (ORAC)
and exercise-induced oxidative stress in trotters.  Eur J Appl
Physiol 2005, 95(5-6):550-556.
39. Prior RL, Cao G: In vivo total antioxidant capacity: comparison
of different analytical methods.  Free Radic Biol Med 1999, 27(11-
12):1173-1181.
40. Mahon M, Toman A, Willan PL, Bagnall KM: Variability of histo-
chemical and morphometric data from needle biopsy speci-
mens of human quadriceps femoris muscle.  J Neurol Sci 1984,
63(1):85-100.
41. Staron RS, Hagerman FC, Hikida RS, Murray TF, Hostler DP, Crill MT,
Ragg KE, Toma K: Fiber type composition of the vastus latera-
lis muscle of young men and women.  J Histochem Cytochem
2000, 48(5):623-629.
42. Khassaf M, Child RB, McArdle A, Brodie DA, Esanu C, Jackson MJ:
Time course of responses of human skeletal muscle to oxi-
dative stress induced by nondamaging exercise.  J Appl Physiol
2001, 90(3):1031-1035.
43. Morton JP, MacLaren DP, Cable NT, Bongers T, Griffiths RD, Camp-
bell IT, Evans L, Kayani A, McArdle A, Drust B: Time course and
differential responses of the major heat shock protein fami-
lies in human skeletal muscle following acute nondamaging
treadmill exercise.  J Appl Physiol 2006, 101(1):176-182.
44. Mattson JP, Ross CR, Kilgore JL, Musch TI: Induction of mitochon-
drial stress proteins following treadmill running.  Med Sci
Sports Exerc 2000, 32(2):365-369.
45. Menshikova EV, Ritov VB, Ferrell RE, Azuma K, Goodpaster BH, Kel-
ley DE: Characteristics of Skeletal Muscle Mitochondrial Bio-
genesis Induced by Moderate-Intensity Exercise and Weight
Loss in Obesity.  J Appl Physiol 2007, 103(1):21-27.
46. Mokhtar N, Lavoie JP, Rousseau-Migneron S, Nadeau A: Physical
training reverses defect in mitochondrial energy production
in heart of chronically diabetic rats.  Diabetes 1993,
42(5):682-687.
47. Turko IV, Murad F: Quantitative protein profiling in heart
mitochondria from diabetic rats.  J Biol Chem 2003,
278(37):35844-35849.
48. Sreekumar R, Sreekumaran Nair K: Skeletal muscle mitochon-
drial dysfunction & diabetes.  Indian J Med Res 2007,
125(3):399-410.
49. Rabol R, Boushel R, Dela F: Mitochondrial oxidative function
and type 2 diabetes.  Appl Physiol Nutr Metab 2006, 31(6):675-683.
50. Gupta S, Knowlton AA: HSP60, Bax, apoptosis and the heart.  J
Cell Mol Med 2005, 9(1):51-58.
51. Civitarese AE, Carling S, Heilbronn LK, Hulver MH, Ukropcova B,
Deutsch WA, Smith SR, Ravussin E: Calorie Restriction Increases
Muscle Mitochondrial Biogenesis in Healthy Humans.  PLoS
Med 2007, 4(3):e76.
52. Sell H, Dietze-Schroeder D, Eckel J: The adipocyte-myocyte axis
in insulin resistance.  Trends Endocrinol Metab 2006,
17(10):416-422.
53. Gjovaag TF, Vikne H, Dahl HA: Effect of concentric or eccentric
weight training on the expression of heat shock proteins in
m. biceps brachii of very well trained males.  Eur J Appl Physiol
2006, 96(4):355-362.
54. Hamilton KL, Staib JL, Phillips T, Hess A, Lennon SL, Powers SK:
Exercise, antioxidants, and HSP72: protection against myo-
cardial ischemia/reperfusion.  Free Radic Biol Med 2003,
34(7):800-809.
55. Powers SK, Quindry J, Hamilton K: Aging, exercise, and cardio-
protection.  Ann N Y Acad Sci 2004, 1019:462-470.
56. Snowling NJ, Hopkins WG: Effects of different modes of exer-
cise training on glucose control and risk factors for compli-
cations in type 2 diabetic patients: a meta-analysis.  Diabetes
Care 2006, 29(11):2518-2527.
57. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI:
Reversal of nonalcoholic hepatic steatosis, hepatic insulin
resistance, and hyperglycemia by moderate weight reduc-
tion in patients with type 2 diabetes.  Diabetes 2005,
54(3):603-608.
58. Paolisso G, D'Amore A, Volpe C, Balbi V, Saccomanno F, Galzerano
D, Giugliano D, Varricchio M, D'Onofrio F: Evidence for a rela-
tionship between oxidative stress and insulin action in non-
insulin-dependent (type II) diabetic patients.  Metabolism 1994,
43(11):1426-1429.
59. Laaksonen DE, Atalay M, Niskanen L, Uusitupa M, Hänninen O, Sen
CK: Increased resting and exercise-induced oxidative stress
in young IDDM men.  Diabetes Care 1996, 19(6):569-574.
60. Hamilton RF Jr., Hazbun ME, Jumper CA, Eschenbacher WL, Holian
A: 4-Hydroxynonenal mimics ozone-induced modulation of
macrophage function ex vivo.  Am J Respir Cell Mol Biol 1996,
15(2):275-282.
61. Liu JF, Chang WY, Chan KH, Tsai WY, Lin CL, Hsu MC: Blood lipid
peroxides and muscle damage increased following intensive
resistance training of female weightlifters.  Ann N Y Acad Sci
2005, 1042:255-261.Page 10 of 11
(page number not for citation purposes)
BMC Endocrine Disorders 2008, 8:3 http://www.biomedcentral.com/1472-6823/8/3Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
62. Cakatay U, Telci A, Salman S, Satman L, Sivas A: Oxidative protein
damage in type I diabetic patients with and without compli-
cations.  Endocr Res 2000, 26(3):365-379.
63. Ascensao A, Magalhaes J, Soares J, Ferreira R, Neuparth M, Marques
F, Oliveira J, Duarte J: Endurance training attenuates doxoru-
bicin-induced cardiac oxidative damage in mice.  Int J Cardiol
2005, 100(3):451-460.
64. Ogonovszky H, Sasvari M, Dosek A, Berkes I, Kaneko T, Tahara S,
Nakamoto H, Goto S, Radak Z: The effects of moderate, stren-
uous, and overtraining on oxidative stress markers and DNA
repair in rat liver.  Can J Appl Physiol 2005, 30(2):186-195.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6823/8/3/prepubPage 11 of 11
(page number not for citation purposes)
